NextAR Hip Platform— 510(k) K252847

Substantially Equivalent

Medacta International S.A.

FDA 510(k) clearance K252847 for NextAR Hip Platform, Substantially Equivalent on 2026-01-09. Applicant: Medacta International S.A..

Clearance details

Applicant: Medacta International S.A.
Product code: Code SBF
Advisory panel: Neurology
Date received: 2025-09-08
Decision date: 2026-01-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Castel San Pietro, CH

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.